Molecular pathology exists within a rapidly changing environment. The Strategic Opportunities Committee asseses the opportunities and challenges in the molecular pathology profession and other environments external to the organization that affect AMP interests.
The Strategic Opportunities Committee carries out the activities listed below and provides relevant reports and recommendations to the Board of Directors:
If you are interested in serving on the Strategic Opportunities Committee, please see the various roles available and the responsibilities of each role by clicking here.
Chair
Jane S. Gibson, MS, PhD
University of Central Florida College of Medicine
Board Member
Yassmine Akkari, PhD
Nationwide Children's Hospital
Member
Panieh Terraf, PhD
Memorial Sloan Kettering Cancer Center (MSKCC)
Member
Estevan Kiernan, MS
Illumina
Member
Jordan Laser, MD
Member
Federico A. Monzon, MD
Genomic Path
Member
Nirali M. Patel, MD
Tempus Labs
Member
Anthony N. Sireci, MD, MS
Loxo-Lilly
President
Maria Arcila, MD
Memorial Sloan Kettering Cancer Center (MSKCC)
Chief Executive Officer
Laurie S. Menser, CAE